U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020026) titled 'Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease' on May 23.
Brief Summary: The study aims to evaluate the burden of tau pathology in people with Sporadic and LRRK2 PD via in vivo imaging using the tau tracer, [18F]PI-2620, and a high resolution PET camera, NeuroEXPLORER.
Study Start Date: May 12
Study Type: INTERVENTIONAL
Condition:
Parkinson's Disease
Intervention:
DRUG: [18F]PI-2620
All participants will undergo PET imaging using the [18F]PI-2620 tau-binding tracer.
Recruitment Status: RECRUITING
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Disclaimer: Curated by HT Syndication....